在心力衰竭中进行非侵入式远程监测:系统性审查
Patrick A Kwaah1, Emmanuel Olumuyide2, Kassem Farhat1
1Department of Internal Medicine, Yale School of Medicine, Waterbury, CT 06708, USA.
Medicina (Kaunas, Lithuania)
|July 30, 2025
概括
针对心力衰竭 (HF) 的非侵入性远程监测显示了患者结局的混合结果. 未来的研究应该专注于患者参与和定制策略,以提高其在管理高频率方面的有效性.
科学领域:
- 心脏病学和数字健康
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心力衰竭 (HF) 是一个重要的全球健康问题,患病率越来越高,医疗保健成本也很高.
- 非侵入式远程监测是管理高频率的潜在工具,但其临床有效性需要进一步澄清.
研究的目的:
- 系统地审查随机对照试验 (RCT),评估心力衰竭的非侵入性远程监测.
- 评估远程监控对HF患者死亡率,再入院率和生活质量 (QoL) 的影响.
- 描述远程监控干预特征的异质性.
主要方法:
- 2004年至2024年间发表的32项RCT的系统审查,包括13,294名参与者.
- 分析的重点是远程监测对HF死亡率,再入院和QOL的有效性.
- 远程监控模式的特征,反频率,临床医生审查触发因素和患者参与水平.
主要成果:
- 非侵入式远程监测显示,对心力衰竭患者的死亡率,再入院率和QoL产生混合影响.
- 移动应用程序是最常见的接口 (53%),定期反 (63%) 和事件触发的临床审查 (44%) 是普遍存在的.
- 大多数远程监控设计具有被动患者角色 (90%) 并显示患者参与度较低.
结论:
- 对于高频率的远程监控干预措施在设计和持续时间上有很大差异,通常患者参与度有限.
- 需要进一步的研究来确定最能对远程监控做出反应的患者子组.
- 完善远程监控策略对于有效补充传统心力衰竭护理至关重要.
相关概念视频
01:30Pulse rhythm
929
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
929
01:30Heart Failure VII: Nursing Interventions
140
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
140
01:30Heart Failure V: Medical Management
25
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
25
01:23Holter Monitor: 24-Hour Monitoring
289
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
289
01:22Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510